Cantharidin for molluscum contagiosum

Area of Science:

• Dermatology
• Pediatrics
• Virology

Background:

• Molluscum contagiosum (MC) is a prevalent viral skin infection in pediatric populations.
• Lesions are often persistent, leading to parental concern and a desire for treatment despite the condition being self-limiting.

Purpose of the Study:

• To explore existing therapeutic options for molluscum contagiosum in children.
• To evaluate the appropriateness and safety of cantharidin as a treatment for pediatric MC.

Main Methods:

• Review of therapeutic strategies for molluscum contagiosum.
• Focus on the application and outcomes of local cantharidin treatment in pediatric cases.

Main Results:

• Cantharidin is a suggested local treatment for MC, typically administered every 3-4 weeks.
• A minimum of two treatment sessions are generally required for efficacy.
• Common side effects include local erythema, burning sensations, and blister formation.

Conclusions:

• Cantharidin presents a viable treatment option for molluscum contagiosum in children.
• Healthcare providers should counsel patients on potential side effects associated with cantharidin therapy.